Related Experiment Video

Updated: Jan 13, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K

Developing an antibody drug encapsulation nanoagent targeting HER2 for cancer treatment

Linrong Li1,2, Ru Yao1, Yan Liu2

  • 1Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Journal of Translational Medicine
|January 8, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Actinomycin DAntibody encapsulated drugBreast cancerSingle protein encapsulationTr-ACT2Trastuzumab

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.4K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.4K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

Beyond ADCs: Antibody-encapsulated drug for targeted cancer therapy.

Cell investigation·2026

STAT3 signaling inhibitors for cancer treatment.

Trends in pharmacological sciences·2026

Social Determinants of Health and Their Role in Basilar Skull Fracture Outcomes: A Level 1 Trauma Multicenter Retrospective Study.

Neurotrauma reports·2026

Despite lower fracture rates, homeless patients have worse outcomes after geriatric ground-level falls: an analysis of National Trauma Data Bank.

OTA international : the open access journal of orthopaedic trauma·2026

The effectiveness and safety of commercial Chinese polyherbal preparation in treating infantile anorexia: a systematic review and Bayesian network meta-analysis.

Frontiers in pharmacology·2026

Study on exploring the relationships between physiological indicators in near-death experiences by drawing on in-mold electronics and node displacement concepts in brain-computer interface signal transmission.

Scientific reports·2026

Current state of research and future developments of artificial intelligence in pain diagnosis and treatment.

Journal of translational medicine·2026

M2-associated microglial states in oligodendrocyte regulation and white matter repair in vascular dementia.

Journal of translational medicine·2026

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Journal of translational medicine·2026

SNX8 regulates BMPR2-mediated SMAD5 proteostasis to drive epithelial-mesenchymal transition in hepatocellular carcinoma.

Journal of translational medicine·2026

Inflammation-linked adipokine profiles associate with acute organ dysfunction after severe trauma.

Journal of translational medicine·2026

Epigenetic regulation of neutrophil dysfunction in sepsis: mechanisms, biomarkers, and translational challenges.

Journal of translational medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us